Subtype and grade classification using histopathologic slides |
Gal Aviram |
Curatio - DL |
PLCO |
Mar 2, 2022 |
PLCOI-924 |
A Deep Learning Model for Improved Cancer Risk Prediction in Sequential Lung Screening X-Rays |
Regina Barzilay |
Massachusetts Institute of Technology |
PLCO |
Feb 17, 2022 |
PLCOI-919 |
Self-supervised Training in chest X-rays domain. |
Song Luo |
Northwestern University |
PLCO |
Feb 16, 2022 |
PLCOI-920 |
Computerized image analysis of morphology, texture on H&E slides of colon cancer patients |
Anant Madabhushi |
Emory University |
PLCO |
Feb 16, 2022 |
PLCOI-917 |
PLCO data integration to PD research as control |
Andrew Singleton |
National Institute of Aging |
PLCO |
Feb 16, 2022 |
PLCO-914 |
Identification and Characterization of Genetic Variants Predisposing Cancer |
Jeffrey Smith |
Vanderbilt University Medical Center |
PLCO |
Feb 16, 2022 |
PLCO-918 |
Bachelor's thesis project: Investigating how machine learning can be applied to predict pancreatic cancer |
Arvid Eriksson |
Royal Institute of Technology (KTH) |
PLCO |
Feb 16, 2022 |
PLCO-916 |
Risk of Prostate Cancer Death in the PLCO Cohort Based on a Four Kallekrein Panel |
Jonathan Shoag |
Case Western Reserve University |
PLCO |
Feb 16, 2022 |
PLCO-912 |
Machine Learning for Breast Cancer Risk Prediction |
Sigrid Sandström |
Stockholm University |
PLCO |
Feb 16, 2022 |
PLCO-910 |
An evaluation of the association between aspirin and NSAID use and changes in body mass index on gastrointestinal cancer incidence and mortality |
Holli Loomans-Kropp |
The Ohio State University |
PLCO |
Feb 15, 2022 |
PLCO-907 |
The Lung EArly Proteins (LEAP) Project |
Hilary Robbins |
International Agency for Research on Cancer |
PLCO |
Feb 3, 2022 |
2021-1022 |
Competing risks analysis of multiple cancers with application to vitamin D in PLCO |
Yei Eun Shin |
Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute |
PLCO |
Feb 2, 2022 |
PLCO-904 |
Development of a ML algorithm to predict ovarian cancer risk |
Nicolas Martelin |
Prostperia SAS |
PLCO |
Jan 27, 2022 |
PLCO-903 |
Lung Cancer Patient's survival analysis |
Sreekanth Settur |
Swiss School of Business and Management |
PLCO |
Jan 27, 2022 |
PLCO-902 |
BMI and the risk of renal cell carcinoma : a case control study |
Benjamin Chung |
Stanford University |
PLCO |
Jan 18, 2022 |
PLCO-896 |
Radiomic analysis of Chest radiographs for prediction of lung cancer outcomes |
Anant Madabhushi |
Emory University |
PLCO |
Jan 18, 2022 |
PLCOI-887 |
Interpretable AI prediction of prostate tumor staging |
Matthias Weidemüller |
Universität Heidelberg |
PLCO |
Jan 18, 2022 |
PLCO-897 |
Threshold quantile regression models with applications to PSA data |
Eun Ryung Lee |
Sungkyunkwan University |
PLCO |
Jan 7, 2022 |
PLCO-893 |
The timing between the diagnosis and the end of the last treatment in the cancer continuum in patients with colon cancer by TNM stages; and the impact of delays in the final survival of the patients, in PLCO, In the period available in the data set. |
Percy Guzman |
Percy Guzman |
PLCO |
Jan 7, 2022 |
PLCO-882 |
Evaluating key determinants for the risk of second primary lung cancer among bladder cancer survivors using population-based screening trial data from the PLCO |
Summer Han |
Stanford University |
PLCO |
Jan 5, 2022 |
PLCO-886 |